NCT02831530View on ClinicalTrials.gov

Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

February 2, 2018

Study Completion Date

February 2, 2018

Conditions

Breast Cancer

Interventions

DRUG

Abemaciclib

Trial Locations (1)

94805

Gustave Roussy, Villejuif

All Listed Sponsors

lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT02831530 - Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients | Biotech Hunter | Biotech Hunter